Evidence map›Paper›PMID 42351487›Full record

ArticleDiagnostics (Basel, Switzerland)2026

Defining When Nusinersen Starts to Work: Time to Clinical Benefit in Patients with SMA Types 1-3 from a Real-World Cohort in China.

Ying Wu, Shuang Li, Yanbin Fan, Yuan Wu, Jie Zhang, Hui Dong, Yao Zhang, Xiaoling Yang, Hui Xiong, Cuijie Wei

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ying WuChildren's Medical Center, Peking University First Hospital, Beijing 102699, China.
Shuang LiChildren's Medical Center, Peking University First Hospital, Beijing 102699, China.
Yanbin FanChildren's Medical Center, Peking University First Hospital, Beijing 102699, China.
Yuan WuChildren's Medical Center, Peking University First Hospital, Beijing 102699, China.ORCID 0000-0003-0582-8889
Jie ZhangChildren's Medical Center, Peking University First Hospital, Beijing 102699, China.
Hui DongChildren's Medical Center, Peking University First Hospital, Beijing 102699, China.ORCID 0000-0001-8154-4007
Yao ZhangChildren's Medical Center, Peking University First Hospital, Beijing 102699, China.
Xiaoling YangChildren's Medical Center, Peking University First Hospital, Beijing 102699, China.
Hui XiongChildren's Medical Center, Peking University First Hospital, Beijing 102699, China.ORCID 0000-0003-4138-2992
Cuijie WeiChildren's Medical Center, Peking University First Hospital, Beijing 102699, China.

Funding

Cyrus Tang Foundation through the project "Early Identification and Intensive Management of Severe Neurogenetic Diseases Affecting Children's Physical and Mental Health"National High Level Hospital Clinical Research Funding (Interdepartmental Research Project of Peking University First Hospital) No. 2023IR51National Natural Science Foundation of China 82402177, 82471430The Beijing High-Level Innovation and Entrepreneurship Talent Support Program-Healthcare Platform young backbone talent projects G202531202
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

efficacyNusinersenreal worldsafetyspinal muscular atrophy

Identifiers

PMID42351487
PMCPMC13297879

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.